Augmentation effect of postprandial hyperinsulinaemia on growth of human hepatocellular carcinoma.
about
Importance of hepatitis C virus-associated insulin resistance: therapeutic strategies for insulin sensitizationSystematic review: Rabeprazole-based therapies in Helicobacter pylori eradication.Chronic hepatitis c genotype-4 infection: role of insulin resistance in hepatocellular carcinoma.Resection of nonalcoholic steatohepatitis-associated hepatocellular carcinoma: a Western experience.Prospective evaluation of type 2 diabetes mellitus on the risk of primary liver cancer in Chinese men and women.Liver and diabetes. A vicious circle.Higher Glucose and Insulin Levels Are Associated with Risk of Liver Cancer and Chronic Liver Disease Mortality among Men without a History of Diabetes.Interaction between hepatitis C virus and metabolic factors.Small molecule inhibitors of the IGF-1R/IR axis for the treatment of cancer.Use of HOMA-IR in hepatitis C.Expression of somatostatin receptors in normal and cirrhotic human liver and in hepatocellular carcinoma.Effect of pioglitazone on outcome following curative treatment for hepatocellular carcinoma in patients with hepatitis C virus infection: A prospective study.Occlusion of portosystemic shunts improves hyperinsulinemia due to insulin resistance in cirrhotic patients with portal hypertension.Branched-chain amino acids improve insulin resistance in patients with hepatitis C virus-related liver disease: report of two cases.Development from simple steatosis to liver cirrhosis and hepatocellular carcinoma: a 27-year follow-up case.Evaluation of a novel non-invasive (13) C-glucose breath test for the identification of diabetes mellitus in cirrhotic patients.The Incidence of Hepatocellular Carcinoma after Balloon-Occluded Retrograde Transvenous Obliteration
P2860
Q33812148-824EEF42-1BF0-4501-8347-CB2A49F906BDQ35086840-1F2EAB46-B3AD-4DC5-8DD5-F9DD3BA0C12AQ35555547-9E48D254-78A5-47E1-B655-1529E32A994FQ36231233-560E6C1F-649D-4D6B-A50E-40B53A904715Q36862827-86952D30-A7E2-4DE7-A4CF-880A6220F07BQ37070333-0398F2E1-4411-402C-8889-123738A961CEQ37389382-D9F5AF9D-6F0F-4E8D-ABA4-DE3896F8A449Q37654443-AFC63A77-B961-4AD4-A0C8-CAE4ECED8A8CQ37859024-42D0C840-C6DE-48E9-8086-AD8C1A608247Q37931383-8B04DFAE-62B5-4270-8F8E-E8EBFF123887Q40537154-8826963B-2E53-4977-889E-B3074E1F66DDQ41621514-47C84BC4-4A76-4BFA-A56F-FCEF5EF9572DQ42264602-B040184A-2B1D-4850-B1CD-99C95C2CF508Q43041205-A656ECC9-A217-445A-881E-A0109E7070D5Q50633557-F0D9D1F6-D0E5-42A7-9EB0-FB6CD5EE80CEQ51356806-6CFFCA1E-BD07-4F47-A3C1-39EA194B8C90Q59103437-A07F1B20-1199-416D-BC58-415A4AC8C908
P2860
Augmentation effect of postprandial hyperinsulinaemia on growth of human hepatocellular carcinoma.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Augmentation effect of postpra ...... uman hepatocellular carcinoma.
@ast
Augmentation effect of postpra ...... uman hepatocellular carcinoma.
@en
type
label
Augmentation effect of postpra ...... uman hepatocellular carcinoma.
@ast
Augmentation effect of postpra ...... uman hepatocellular carcinoma.
@en
prefLabel
Augmentation effect of postpra ...... uman hepatocellular carcinoma.
@ast
Augmentation effect of postpra ...... uman hepatocellular carcinoma.
@en
P2093
P2860
P356
P1433
P1476
Augmentation effect of postpra ...... uman hepatocellular carcinoma.
@en
P2093
H Watanabe
P2860
P304
P356
10.1136/GUT.51.1.100
P407
P577
2002-07-01T00:00:00Z